Jaroslav Juráček, Ph.D.

Publications that are part of the Web of Science database, possibly also other publications chosen by authors.

2021

• Andrasina, T; Juracek, J; Zavadil, J; Cechova, B; Rohan, T; Vesela, P; Paldor, M; Slaby, O; Goldberg, SN, 2021: Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY 32(3), p. 403 - 411, doi: 10.1016/j.jvir.2020.10.024

2020

• Barth, DA; Juracek, J; Slaby, O; Pichler, M; Calin, GA, 2020: lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System. CANCERS 12(8), doi: 10.3390/cancers12082148

2019

• Barth, DA; Slaby, O; Klec, C; Juracek, J; Drula, R; Calin, GA; Pichler, M, 2019: Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. CANCERS 11(10), doi: 10.3390/cancers11101580
• Kovacova, J; Juracek, J; Poprach, A; Kopecky, J; Fiala, O; Svoboda, M; Fabian, P; Radova, L; Brabec, P; Buchler, T; Slaby, O, 2019: MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients. CANCER GENOMICS & PROTEOMICS 16(5), p. 353 - 359, doi: 10.21873/cgp.20140
• Juracek, J; Piler, P; Janku, P; Radova, L; Slaby, O, 2019: Identification of microRNA signatures in umbilical cord blood associated with maternal characteristics. PEERJ 7, doi: 10.7717/peerj.6981
• Juracek, J; Stanik, M; Vesela, P; Radova, L; Dolezel, J; Svoboda, M; Slaby, O, 2019: Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 37(3), doi: 10.1016/j.urolonc.2018.10.014

2018

• Juracek, J; Peltanova, B; Dolezel, J; Fedorko, M; Pacik, D; Radova, L; Vesela, P; Svoboda, M; Slaby, O; Stanik, M, 2018: Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 22(3), p. 2033 - 2038, doi: 10.1111/jcmm.13487
• Kopkova, A; Sana, J; Fadrus, P; Machackova, T; Vecera, M; Vybihal, V; Juracek, J; Vychytilova-Faltejskova, P; Smrcka, M; Slaby, O, 2018: MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study. PLOS ONE 13(12), doi: 10.1371/journal.pone.0208580
• Kovacova, J; Juracek, J; Poprach, A; Buchler, T; Kopecky, J; Fiala, O; Svoboda, M; Slaby, O, 2018: Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor Response. ANTICANCER RESEARCH 38(5), p. 2961 - 2965, doi: 10.21873/anticanres.12546

2017

• Fedorko, M; Juracek, J; Stanik, M; Svoboda, M; Poprach, A; Buchler, T; Pacikl, D; Dolezel, J; Slaby, O, 2017: Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma. BIOCHEMIA MEDICA 27(2), p. 411 - 417, doi: 10.11613/BM.2017.043
• Lakomy, R; Poprach, A; Bortlicek, Z; Melichar, B; Chloupkova, R; Vyzula, R; Zemanova, M; Kopeckova, K; Svoboda, M; Slaby, O; Kiss, I; Studentova, H; Juracek, J; Fiala, O; Kopecky, J; Finek, J; Dusek, L; Hejduk, K; Buchler, T, 2017: Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. BMC CANCER 17, doi: 10.1186/s12885-017-3901-5

2016

• Iliev, R; Kleinova, R; Juracek, J; Dolezel, J; Ozanova, Z; Fedorko, M; Pacik, D; Svoboda, M; Stanik, M; Slaby, O, 2016: Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer. TUMOR BIOLOGY 37(10), p. 13385 - 13390, doi: 10.1007/s13277-016-5177-9
• Fedorko, M; Pacik, D; Wasserbauer, R; Juracek, J; Varga, G; Ghazal, M; Nussir, MI, 2016: MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 31(1), p. E26 - E37, doi: 10.5301/jbm.5000174

2015

• Slaby, O; Srovnal, J; Radova, L; Gregar, J; Juracek, J; Luzna, P; Svoboda, M; Hajduch, M; Ehrmann, J, 2015: Dynamic changes in microRNA expression profiles reflect progression of Barrett´s esophagus to esophageal adenocarcinoma. CARCINOGENESIS 36(5), p. 521 - 527, doi: 10.1093/carcin/bgv023

• Molecular classification of renal cell carcinoma based on long noncoding RNAs expression and its implication for diagnosis, prognosis and therapy, Ministry of Health of the CR, 2018 - 2021
• Národní centrum lékařské genomiky (LM2015091), Ministerstvo školství, mládeže a tělovýchovy ČR, 2016 - 2019
• Studium mikroRNA a genů asociovaných s procesem epiteliálně-mezenchymální tranzice jako potenciálních markerů pro predikci rizika a časný záchyt metastazování u pacientů s renálním karcinomem (NT13547-4/2012), Ministry of Health of the CR, 2012 - 2015
• Development of diagnostic panel of circulating microRNAs for non-invasive early diagnostics and follow-up of colorectal cancer patients (NT/13549), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Analysis of EGFR signalling and microRNA expression profiles in prediction of response to anti-EGFR (NT/13860), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• MicroRNA analysis in glioblastoma stem cells: prediction of therapy response and identification of new therapeutic targets in glioblastoma patients (NT/13514), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Complex characterization of molecular genetic changes in glioblastoma multiforme and its relapses, and evaluation of their possible significance in oncologic therapy and therapy effect (NT/13581), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Development of microRNA diagnostic panel for identification Barret esophagus patients at high-risk of progression to adenocarcinoma (NT13585), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2014
• Identification and functional characterization of microRNAs with predictive significance in patients with glioblastoma (NT/11214), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2013